Live Breaking News & Updates on Chula Vaccine Research Center|Page 3

Stay updated with breaking news from Chula vaccine research center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TFF Pharmaceuticals, Inc. (TFFP) Q1 2021 Earnings Call Transcript

TFF Pharmaceuticals, Inc. (TFFP) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP)
Q1 2021 Earnings Call
Thank you for standing by. Welcome the TFF Pharmaceuticals Inc. first-quarter 2021 financial and business results conference call. [Operator instructions] As a reminder, today s program may be recorded.Now I like to introduce your host for today s program Paul Sagan, investor relations.
Please go ahead, sir.
Investor Relations
Thank you, operator. Hello, everyone, and welcome to TFF Pharmaceuticals first-quarter 2021 financial and business results conference call. With me on the line today is Glenn Mattes, president and chief executive officer of TFF; Kirk Coleman, chief financial officer; Dr. Dale Christensen, TFF s director of clinical development; Dr. ....

Puerto Rico , South Africa , San Antonio , United States , United Kingdom , South African , Kartik Chandran , Bill Morrison , Kiat Ruxrungtham , Ted Ross , Ram Selvaraju , Mount Rushmore , Dale Christensen , Albert Einstein , Paul Sagan , John Dye , Daniel Carlson , Karthik Chandran , Absas Chris , Jonathan Aschoff , Augmenta Bioworks , Kirk Coleman , Bill Williams , Chula Vrcs , Rob Mcbride , Felix Bio ,

Thailand: Covid-19 and the Vaccine

Article by Anthony Margetts CEng MIChemE
How the Covid-19 vaccine development is progressing in Thailand
THAILAND is a developing country in the Asean Region of SE Asia with a population of 66m and also several million migrant workers from Myanmar and Cambodia who work in the food production and construction industries. In 2019 Thailand received 35m visitors from many parts of the world to visit the spectacular beaches, mountains and temples. A dramatic consequence of the Covid-19 pandemic is that there are now no visitors, and the tourist areas are very quiet.
Thailand is also a globally-renowned wellness hub and has attracted millions of foreign patients in previous years. Its public healthcare is highly rated, and was ranked the sixth-best healthcare provider in 2019, according to analysis conducted by magazine ....

Krung Thep Mahanakhon , Bang Khae , New South Wales , United States , South Korea , Sara Buri , Pathum Thani , Boonrak Thawornrungroaj , Nick White , King Monkut , Baiya Phytopharm , Nakorn Premsri , Queen Savang Vadhana , Human Research Ethics Committee , National Health Security Office , Faculty Of Tropical Medicine At Mahidol University , Merieux Biological Products Co , Government Pharmaceutical Organization , University Of Sydney , Health Coverage , Oxford University , National Vaccine Committee , National Vaccine Institute , Chulalongkorn University Faculty Of Pharmaceutical Sciences , Texas University , Department Of Disease Control ,

nikkei.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nikkei.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Hong Kong , Hai Duong , Hi Duong , Republic Of , Cape Town , Western Cape , South Africa , Rio De Janeiro , Estado Do Rio , Tanah Abang , Sumatera Utara , New Zealand , Jawa Timur , South Korea , Jakarta Raya , Metropolitan Manila , Philippines General , Toshkent Shahri , White House , District Of Columbia , Soult Ukpyolsi , Republic Of Korea , South Korean , South African ,

Vaccine set to undergo human trials

Latest news: Anutin (second from left) holding a news conference to give an update on the progress of the ‘ChulaCov19’ vaccine in Bangkok. Reuters
The country’s second domestically developed vaccine will soon undergo human trials, officials said, adding that the plan was to produce up to five million doses by the end of the year.
The vaccine, developed by Thailand’s Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said.
“By year-end we should have a production capacity of one to five million doses annually, ” Kiat told a news conference yesterday, adding this could later rise to about 20 million doses per year. ....

South Africa , United States , Maha Sarakham , United Kingdom , Khon Kaen , South African , Bionet Asia , Kiat Ruxrungtham , Panya Hanphanitphan , Anutin Charnvirakul , Mahidol University , Centre For Covid , Chula Vaccine Research Center , Thailand Chulalongkorn University , Situation Administration , Chulalongkorn University , Siam Bioscience , Mahasarakham Hospital , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கோன் கான் , சூலா தடுப்பூசி ஆராய்ச்சி மையம் , தாய்லாந்து சுழலங்காரன் பல்கலைக்கழகம் , சுழலங்காரன் பல்கலைக்கழகம் , சியாம் உயிர் அறிவியல் ,

Thai-developed COVID-19 vaccine set to proceed to human trials

BANGKOK: Thailand's second domestically developed COVID-19 vaccine will soon undergo human trials, officials said on Thursday (Feb 18), adding . ....

Krung Thep Mahanakhon , South Africa , United States , United Kingdom , South African , Bionet Asia , Kiat Ruxrungtham , Anutin Charnvirakul , Mahidol University , Thailand Chulalongkorn University , Chula Vaccine Research Center , Chulalongkorn University , Siam Bioscience , Covid 19 , Corona Virus , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , தாய்லாந்து சுழலங்காரன் பல்கலைக்கழகம் , சூலா தடுப்பூசி ஆராய்ச்சி மையம் , சுழலங்காரன் பல்கலைக்கழகம் , சியாம் உயிர் அறிவியல் , கொரோனா வைரஸ் ,